Key Information
Source
Amyloid: The Official Journal of the International Society of Amyloidosis
Year
2021
summary/abstract
A reliable diagnosis of amyloidosis is usually based on a tissue biopsy. With increasing options for specific treatments of the different amyloid diseases, an exact and valid diagnosis including determination of the biochemical fibril nature is imperative. Biopsy sites as well as amyloid typing principles vary and this paper describes methods employed at some laboratories specialised in amyloidosis in Europe, Japan and USA.
Abstract Source
https://www.tandfonline.com/doi/full/10.1080/13506129.2021.1994386
DOI
10.1080/13506129.2021.1994386
Pubdate
November 12, 2021
Organisation
Indiana University School of Medicine, USA; Boston University School of Medicine, USA; Mayo Clinic, USA; AP-HP Henri-Mondor Teaching Hospital and UPEC, France; University College London, UK; University Medical Center Groningen, The Netherlands; IRCCS Policlinico San Matteo and University of Pavia, Italy; Loyola University Medical Center, USA; University-Hospital Schleswig-Holstein, Germany; University Hospital Heidelberg, Germany; Kumamoto University, Japan; Uppsala University, Sweden